Artificial Insemination Market Size, Share, Outlook, and Opportunity Analysis, 2022-2028
Artificial Insemination Market |
A medical procedure known as
artificial insemination involves placing sperm in a female's uterus on purpose
through methods other than sexual contact in order to induce pregnancy. Human
fertility treatments like artificial insemination are also frequently used in
animal breeding. Those who receive artificial insemination include infertile
couples and single mothers. The most extensively used artificial insemination
technique is intrauterine insemination (IUI).
The Artificial
Insemination Market is expanding as the prevalence of
infertility rises. For instance, studies found that 48.5 million couples
worldwide were unable to have a child in 2010. These findings were reported in
the 2012 PLOS Medicine journal. Home-use kits, including as ovulation kits,
pregnancy detection kits, and insemination devices, are frequently offered by
market participants.
The expansion of the Artificial
Insemination Market is being fueled by major pharmaceutical firms'
aggressive development of medications that are undergoing clinical and
preclinical testing as well as their introduction of new insemination kits with
proven potential benefits. For instance, a 2015 clinical trial study of the
Stork OTC kit demonstrated its efficiency in delivering sperm to the cervix in
higher concentrations than during sexual activity. Around 85% of the trial
participants had a 3.23x increase in sperm concentration from the Stork OTC,
while the other 15% experienced no change in sperm concentration at the
cervix.
In July 2014, the FDA granted
over-the-counter approval for the Stork OTC. The kit aids in the collection,
insertion, and transportation of sperms directly at the cervix's entrance for a
prolonged period of time, giving them the chance to enter the uterus. The Stork
OTC offers customers a secure and convenient way to administer sperm without
creating an adverse vaginal environment. Additionally, the National Women's
Health Resource Center estimates that over 20 million women are affected by
infertility. The total fertility rate (children per woman) is predicted to fall
from 2.43 to 2.39 between 2020 and 2030, according to the 2017 United Nations
World Population Prospects report. The prevalence of infertility among the
world's population is rising, which is significantly accelerating the Artificial
Insemination Market.
The size of the artificial
insemination market is being hampered by the strict laws that are being set by
the majority of nations about who is eligible to get reproductive treatments.
For example, gay couples and single women are prohibited from utilising
artificial insemination in Italy and France. All sperm and egg contributions
for IVF are prohibited in Austria and Italy, among other countries. Germany and
Norway forbid egg donations but permit sperm contributions.
Comments
Post a Comment